로딩 중…
지수 로딩 중…
티디에스팜
464280· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩4,480-0.44%
2026-11-02
Financials
Valuation Metrics
티디에스팜's Market Cap is ₩248B. At end of 2025 it was ₩545B. Ranked #2137 of 2,410 in KR market (top 89%), #1383 of 1,631 on KOSDAQ (top 85%), #218 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 94%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 24.77B KRW | KR#2,137/2,410 Sec#218/231 |
| Revenue | 32.90B KRW | KR#1,991/2,410 Sec#137/231 |
| Net Income | 5.15B KRW | KR#1,197/2,410 Sec#78/231 |
| Total Assets | 63.71B KRW | KR#2,068/2,410 Sec#179/231 |
| Net Assets | 44.89B KRW | KR#1,972/2,410 Sec#169/231 |
| Employees | 96 | KR#1,666/2,410 Sec#130/231 |
| Value | ||
| P/E | 4.81x | KR#400/2,410 Sec#14/231 |
| P/B | 0.55x | KR#995/2,410 Sec#54/231 |
| PEG | 0.10x | KR#434/2,410 Sec#22/231 |
| P/S | 0.75x | KR#1,272/2,410 Sec#68/231 |
| EV/EBITDA | 6.35x | KR#382/2,410 Sec#13/231 |
| Profitability | ||
| ROE | 11.48% | KR#509/2,410 Sec#35/231 |
| ROA | 8.09% | KR#435/2,410 Sec#32/231 |
| Op. Margin | 17.14% | KR#231/2,410 Sec#21/231 |
| Revenue Growth | 0.37% | KR#1,501/2,410 Sec#150/231 |
| Earnings Growth | 48.88% | KR#566/2,410 Sec#37/231 |
| Financial Health | ||
| Debt Ratio | 41.93% | KR#829/2,410 Sec#96/231 |
| Total Debt | 13.80B KRW | KR#1,516/2,410 Sec#132/231 |
| Cash | 2.76B KRW | KR#2,182/2,410 Sec#208/231 |
| Current Ratio | 2.00x | KR#868/2,410 Sec#99/231 |
| Net Debt/EBITDA | 1.96x | KR#833/2,410 Sec#60/231 |
| Performance | ||
| 1Y Return | -50.28% | KR#1,969/2,410 Sec#173/231 |
| 1M Return | -16.88% | KR#1,652/2,410 Sec#163/231 |
| From 52W High | -58.52% | KR#1,538/2,410 Sec#127/231 |
| 1Y MDD | -57.33% | KR#1,271/2,410 Sec#105/231 |
| Trading | ||
| Volume | 4,174 shares | KR#2,156/2,410 Sec#215/231 |
| Trading Value | 18.7M KRW | KR#2,095/2,410 Sec#220/231 |
| Foreign Own. | 3.52% | KR#1,145/2,410 Sec#105/231 |
| Per Share | ||
| EPS | 932 KRW | KR#755/2,410 Sec#52/231 |
| BPS | 8,118 KRW | KR#1,125/2,410 Sec#82/231 |
Company Info
Established on November 11, 2002, TDS Pharm Co. Ltd. is headquartered in Seongnam-si, South Korea, and specializes in the creation and manufacturing of transdermal drug delivery solutions. Their offerings include items such as cataplasma, plasta, fucidin band, and various prescription pharmaceuticals.